Knopp Biosciences Llc Is A Privately Held Company Founded In 2004Originally Focused On Drug Discovery And Development For Immunological And Neurological Diseasesthe Company Is No Longer Operationalwith Its Former Employees Moving To Other Organizations Such As Biohaven And Areteia Historicallyknopp Was Known For Developing Treatments For Neurological Disordersincluding The Compound Dexpramipexole For Conditions Like Amyotrophic Lateral Sclerosisalsand Eosinophilic Asthmathis Compound Is Now Being Advanced By Areteia Therapeuticsknopp Also Worked On The Kv7 Platformwhich Involved Small Molecule Treatments For Epilepsy And Other Hyperexcitability Disordersnow Further Developed By Biohaven Pharmaceuticalsadditionallythe Company Explored Treatments For Chronic Pain Through Kv7 2 3 Activators Currentlyknopp Biosciences Manages A Portfolio Of Equity Securities And Future Product Royaltiesthe Company Is Preparing To Launch An Investor Portal To Provide Access To Financial Information For Its Members
No conferences found for this company.
| Company Name | Knopp Biosciences Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
